Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Effect of Neflamapimod (VX-745) on Brain Inflammation Using Positron Emission Tomography (PET) Scan in Alzheimer's Disease (AD) Patients

NCT03435861 is registered in ClinicalTrials.gov with University Hospital, Toulouse as lead sponsor.

NCT NCT03435861
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03435861 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Effect of Neflamapimod (VX-745) on Brain Inflammation Using Positron Emission Tomography (PET) Scan in Alzheimer's Disease (AD) Patients
Lead sponsor
University Hospital, Toulouse
Phase
Phase 2
Overall status
Completed
Start date
October 8, 2018
Completion date
June 30, 2021
Enrollment
34 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

alzheimer disease